Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 2
1984 2
1986 2
1988 2
1989 4
1990 1
1991 1
1996 1
1997 1
1999 1
2001 1
2002 1
2003 1
2007 2
2008 3
2009 6
2010 5
2011 3
2012 10
2013 5
2014 9
2015 10
2016 7
2017 7
2018 9
2019 3
2020 12
2021 7
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Lung Cancer in the Czech Republic.
Borilova S, Dusek L, Jakubikova L, Turcani P, Matej R, Hanke I, Dymackova R, Bilek O, Pauk N, Svoboda M. Borilova S, et al. Among authors: turcani p. J Thorac Oncol. 2023 Mar;18(3):271-277. doi: 10.1016/j.jtho.2022.11.023. J Thorac Oncol. 2023. PMID: 36842812 Free article. No abstract available.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A, Mundl H, Smith EE, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas JL, Dong Q, Turcani P, Christensen H, Ferro JM, Veltkamp R, Mikulik R, De Marchis GM, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren AG, Demchuk AM, Colorado P, Kirsch B, Neumann C, Heenan L, Xu L, Connolly SJ, Hart RG; PACIFIC-Stroke Investigators. Shoamanesh A, et al. Among authors: turcani p. Lancet. 2022 Sep 24;400(10357):997-1007. doi: 10.1016/S0140-6736(22)01588-4. Epub 2022 Sep 2. Lancet. 2022. PMID: 36063821 Clinical Trial.
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020.
Aguiar de Sousa D, Wilkie A, Norrving B, Macey C, Bassetti C, Tiu C, Roth G, Lunde G, Christensen H, Fiehler J, Pezzella FR, Dichgans M, Roaldsen MB, Kelly P, Mikulik R, Sacco S, Caso V, Fischer U; Steering Committee for the Implementation of the Stroke Action Plan in Europe. Aguiar de Sousa D, et al. Eur Stroke J. 2023 Sep;8(3):618-628. doi: 10.1177/23969873231186042. Epub 2023 Jul 11. Eur Stroke J. 2023. PMID: 37431768 Free PMC article.
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG; PACIFIC-Stroke Steering Committee and Investigators. Smith EE, et al. Stroke. 2024 Feb;55(2):392-402. doi: 10.1161/STROKEAHA.123.043198. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174569 Clinical Trial.
Impairment of endothelial function in Parkinson's disease.
Kollár B, Blaho A, Valovičová K, Poddaný M, Valkovič P, Straka I, Turčáni P, Šiarnik P. Kollár B, et al. Among authors: turcani p. BMC Res Notes. 2022 Sep 5;15(1):284. doi: 10.1186/s13104-022-06176-z. BMC Res Notes. 2022. PMID: 36064624 Free PMC article.
Baroreflex: a new therapeutic target in human stroke?
Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Sykora M, et al. Among authors: turcani p. Stroke. 2009 Dec;40(12):e678-82. doi: 10.1161/STROKEAHA.109.565838. Epub 2009 Oct 15. Stroke. 2009. PMID: 19834010 Review.
124 results